X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761052
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125117
https://www.prnewswire.com/news-releases/biomarin-to-present-data-highlighting-significant-impact-of-voxzogo-vosoritide-in-bone-health-and-health-related-quality-of-life-in-achondroplasia-at-2024-international-conference-on-childrens-bone-health-302173608.html
https://www.prnewswire.com/news-releases/biomarin-presents-new-phase-3-four-year-data-underscoring-long-term-safety-and-efficacy-of-roctavian-valoctocogene-roxaparvovec-rvox-at-international-society-on-thrombosis-and-haemostasis-2024-congress-302166583.html
https://www.labpulse.com/diagnostic-technologies/emerging-technology/article/15670927/biomarin-confirms-layoffs-and-rd-cuts
https://www.fiercebiotech.com/biotech/biomarin-sheds-170-jobs-wake-narrowed-rd-refocus
https://investors.biomarin.com/news/news-details/2024/BioMarin-to-Present-at-the-BofA-Securities-2024-Health-Care-Conference-on-Wednesday-May-15-at-1000am-PT--100pm-ET-in-Las-Vegas-NV/default.aspx
https://investors.biomarin.com/news/news-details/2024/New-Data-for-BioMarins-VOXZOGO-vosoritide-for-Multiple-Growth-Related-Conditions-in-Children-Presented-at-Pediatric-Endocrine-Society-PES-Annual-Meeting/default.aspx
https://www.fiercebiotech.com/biotech/under-new-leadership-biomarin-axes-4-candidates-and-centers-3-assets
https://www.prnewswire.com/news-releases/biomarin-reports-record-financial-results-for-the-first-quarter-2024-302125449.html
Market Place
Share 
